265 related articles for article (PubMed ID: 26494953)
21. PD-L1 Testing in Cancer: Challenges in Companion Diagnostic Development.
Hansen AR; Siu LL
JAMA Oncol; 2016 Jan; 2(1):15-6. PubMed ID: 26562503
[No Abstract] [Full Text] [Related]
22. The evolving potential of companion diagnostics.
Khoury JD
Scand J Clin Lab Invest Suppl; 2016; 245():S22-5. PubMed ID: 27433788
[TBL] [Abstract][Full Text] [Related]
23. HER2 testing in gastric cancer: An update.
Abrahao-Machado LF; Scapulatempo-Neto C
World J Gastroenterol; 2016 May; 22(19):4619-25. PubMed ID: 27217694
[TBL] [Abstract][Full Text] [Related]
24. Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.
Nakamura J; Tanaka T; Kitajima Y; Noshiro H; Miyazaki K
World J Gastroenterol; 2014 Sep; 20(34):11991-2006. PubMed ID: 25232236
[TBL] [Abstract][Full Text] [Related]
25. Personalizing therapies for gastric cancer: molecular mechanisms and novel targeted therapies.
Luis M; Tavares A; Carvalho LS; Lara-Santos L; Araújo A; de Mello RA
World J Gastroenterol; 2013 Oct; 19(38):6383-97. PubMed ID: 24151357
[TBL] [Abstract][Full Text] [Related]
26. Dawn of precision medicine on gastric cancer.
Ishii T; Kawazoe A; Shitara K
Int J Clin Oncol; 2019 Jul; 24(7):779-788. PubMed ID: 30976939
[TBL] [Abstract][Full Text] [Related]
27. MET-targeted therapy for gastric cancer: the importance of a biomarker-based strategy.
Kawakami H; Okamoto I
Gastric Cancer; 2016 Jul; 19(3):687-95. PubMed ID: 26690587
[TBL] [Abstract][Full Text] [Related]
28. Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer.
Meric-Bernstam F; Johnson AM; Dumbrava EEI; Raghav K; Balaji K; Bhatt M; Murthy RK; Rodon J; Piha-Paul SA
Clin Cancer Res; 2019 Apr; 25(7):2033-2041. PubMed ID: 30442682
[TBL] [Abstract][Full Text] [Related]
29. Recent advances and future trends in the targeted therapy of metastatic gastric cancer.
Al-Batran SE; Werner D
Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):555-69. PubMed ID: 24665840
[TBL] [Abstract][Full Text] [Related]
30. Targeting receptor tyrosine kinases in gastric cancer.
Morishita A; Gong J; Masaki T
World J Gastroenterol; 2014 Apr; 20(16):4536-45. PubMed ID: 24782606
[TBL] [Abstract][Full Text] [Related]
31. Predictive biomarkers for targeted and cytotoxic agents in gastric cancer for personalized medicine.
Wang S; Yuan L
Biosci Trends; 2016 Jul; 10(3):171-80. PubMed ID: 27251446
[TBL] [Abstract][Full Text] [Related]
32. Precision cancer medicine: the future is now, only better.
Tsimberidou AM; Eggermont AM; Schilsky RL
Am Soc Clin Oncol Educ Book; 2014; ():61-9. PubMed ID: 24857061
[TBL] [Abstract][Full Text] [Related]
33. MiRNA as potential biomarkers and therapeutic targets for gastric cancer.
Shin VY; Chu KM
World J Gastroenterol; 2014 Aug; 20(30):10432-9. PubMed ID: 25132759
[TBL] [Abstract][Full Text] [Related]
34. Gastric cancer in the era of molecularly targeted agents: current drug development strategies.
Arkenau HT
J Cancer Res Clin Oncol; 2009 Jul; 135(7):855-66. PubMed ID: 19363621
[TBL] [Abstract][Full Text] [Related]
35. Personalised Treatment in Gastric Cancer: Myth or Reality?
Tarazona N; Gambardella V; Huerta M; Roselló S; Cervantes A
Curr Oncol Rep; 2016 Jul; 18(7):41. PubMed ID: 27215435
[TBL] [Abstract][Full Text] [Related]
36. Novel biomarkers for the identification and targeted therapy of gastric cancer.
Liu L; Cao L; Gong B; Yu J
Expert Rev Gastroenterol Hepatol; 2015; 9(9):1217-26. PubMed ID: 26220043
[TBL] [Abstract][Full Text] [Related]
37. Gastric cancer: somatic genetics as a guide to therapy.
Zhang XY; Zhang PY
J Med Genet; 2017 May; 54(5):305-312. PubMed ID: 27609016
[TBL] [Abstract][Full Text] [Related]
38. Present and future molecular testing of lung carcinoma.
Dacic S; Nikiforova MN
Adv Anat Pathol; 2014 Mar; 21(2):94-9. PubMed ID: 24508692
[TBL] [Abstract][Full Text] [Related]
39. "Right drug for the right patient": hurdles and the path forward in colorectal cancer.
Kopetz S
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714474
[TBL] [Abstract][Full Text] [Related]
40. Novel targeted agents for gastric cancer.
Liu L; Wu N; Li J
J Hematol Oncol; 2012 Jun; 5():31. PubMed ID: 22709792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
